PCH
EW icon

Polar Capital Holdings’s Edwards Lifesciences EW Stock Holding History

Polar Capital Holdings’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.9M Buy
+1,104,860
New +$92.6M 0.24% 84
2025
Q4 		– Sell
-317,886
Closed -$24.7M – 278
2025
Q3 		$24.7M Buy
317,886
+63,208
+25% +$4.94M 0.12% 133
2025
Q2 		$19.9M Buy
+254,678
New +$19M 0.1% 146
2023
Q1 		– Sell
-76,063
Closed -$5.68M – 306
2022
Q4 		$5.68M Sell
76,063
-21,505
-22% -$1.66M 0.05% 232
2022
Q3 		$8.06M Buy
97,568
+2,954
+3% +$284K 0.05% 213
2022
Q2 		$9M Sell
94,614
-2,065
-2% -$214K 0.05% 203
2022
Q1 		$11.4M Buy
96,679
+2,096
+2% +$235K 0.05% 218
2021
Q4 		$12.3M Buy
94,583
+9,338
+11% +$1.09M 0.05% 216
2021
Q3 		$9.65M Buy
85,245
+3,678
+5% +$420K 0.04% 236
2021
Q2 		$8.45M Buy
+81,567
New +$7.69M 0.04% 243

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Polar Capital Holdings's EW Position: Q2 2026 in Review

Polar Capital Holdings opened a new position in Edwards Lifesciences (EW) in Q2 2026: 1,104,860 shares worth $99.9M. The stake represents 0.24% of the portfolio and ranks #84 among its holdings. This is a return to the name: Polar Capital Holdings previously reported a position in EW as recently as Q3 2025.

Polar Capital Holdings first reported a position in EW in Q2 2021 and has held it in 10 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Polar Capital Holdings held 1,104,860 shares of Edwards Lifesciences worth $99.9M as of Q2 2026.
  • Edwards Lifesciences was a new Polar Capital Holdings position in Q2 2026.
  • Edwards Lifesciences made up 0.24% of Polar Capital Holdings's portfolio in Q2 2026, its #84 holding.
  • Polar Capital Holdings first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 10 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.